Constellium Jumps 101.5% Over the Past Year: Does the Stock Remain a Good Investment?
Constellium SE Stock Shows Remarkable Growth
Investors in Constellium SE (CSTM) have recently enjoyed notable short-term gains. Over the past year, shares of this prominent aluminum products manufacturer have soared by 101.5%, outperforming both the metal products industry and the S&P 500, which saw increases of 94.7% and 23.4%, respectively.
Constellium has also surpassed competitors such as Alcoa Corporation (AA) and Ryerson Holding Corporation (RYZ). Alcoa’s stock rose 96.6%, while Ryerson experienced a decline of 6.1% during the same period.
Performance Highlights: CSTM Leads the Pack
Source: Zacks Investment Research
On Thursday, CSTM closed at $24.59, which is below its 52-week peak of $27.41 but well above its 52-week low of $7.33. The stock is currently trading above both its 50-day and 200-day moving averages, signaling strong momentum and price stability.
Technical Analysis: Moving Averages
Source: Zacks Investment Research
Key Growth Drivers for Constellium
The Packaging & Automotive Rolled Products segment is currently fueling Constellium’s growth. In 2025, shipments in this segment climbed 6% year-over-year to 1,086,000 metric tons, supported by robust demand. Segment revenue jumped 21% to $5.1 billion, thanks to higher metal prices. Increased orders for packaging rolled products in North America and Europe, as well as automotive rolled products in North America, are propelling performance.
Additionally, the Aerospace & Transportation segment is contributing positively. Shipments reached 207,000 metric tons in 2025, and revenue rose 8% to nearly $2 billion, driven by strong demand and favorable metal prices. Orders for transportation, industrial, and defense rolled products remain healthy.
The Automotive Structures & Industry segment is also seeing gains, with shipments totaling 202,000 metric tons and revenue up 10% to about $1.6 billion. Overall, Constellium’s total revenue for the year surged 15% to $8.5 billion compared to the previous year, supported by segment strength and rising metal prices.
Constellium is expected to benefit from elevated aluminum prices, which have been impacted by disruptions in the Strait of Hormuz due to the Israel-Iran conflict, affecting regional supply and boosting global prices.
The company continues to prioritize shareholder returns, generating $178 million in free cash flow in 2025 and repurchasing approximately $115 million in shares. The board recently approved a new buyback program to acquire up to $300 million in shares, effective from May 21, 2026, through December 31, 2028. Cost management remains a focus, with leverage reduced to 2.5x by year-end 2025.
Valuation Insights
Constellium’s forward 12-month price-to-earnings ratio stands at 11.62, below the industry average of 12.51. This positions CSTM as an appealing option for investors. In comparison, Alcoa and Ryerson are trading at higher multiples of 12.54 and 14.03, respectively.
Forward Price-to-Earnings Comparison
Source: Zacks Investment Research
Upward Revisions in Earnings Estimates
Analysts have become increasingly optimistic about CSTM, with earnings estimates rising over the past two months. Projections for 2026 have increased by 20.6% to $2.05 per share, while estimates for 2027 have climbed 18.9% to $2.39 per share during the same period.
Source: Zacks Investment Research
Is Now the Time to Invest in CSTM?
Constellium’s strong presence in the packaging and aerospace sectors, combined with favorable metal prices, sets the stage for continued growth. The company’s commitment to shareholder value and its attractive valuation further boost investor confidence.
With positive analyst sentiment and robust growth prospects, CSTM stands out as a compelling opportunity for investors.
Additional Resources and Reports
Zacks Investment Research
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
3 Top-Rated Stocks Under $10 to Consider Buying
Engineers Gate Reduces Holdings in Sabra Health Care REIT Amid Investor Focus on Rental Revenue Patterns
IBRX Stock: Anktiva Receives Approvals and Future Steps Ahead
